Brief: Universal Biosensors Inc Says Entered Into Master Collaboration Agreement With Mayo Clinic Biopharma Diagnostics
10/11/2021 22:07
Nov 11 (Reuters) - Universal Biosensors Inc UBI.AX :
* ENTERED INTO MASTER COLLABORATION AGREEMENT WITH MAYO
CLINIC
BIOPHARMA DIAGNOSTICS
* AGREEMENT COVERS MULTIPLE POTENTIAL PROJECTS INCLUDING
WORK ON
UBI'S TN ANTIGEN CANCER BIOSENSOR
Source text for Eikon: ID:nASX6qyJcK
Further company coverage: UBI.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Universal Biosensors
See all newsBrief: Universal Biosensors Seeks Trading Halt Pending Announcement On Financial Position & Funding
Brief: Universal Biosensors Signs Non-Binding Term Sheet For A$8.5M Funding
Brief: Universal Biosensors Seeks Trading Halt
Brief: Universal Biosensors Inc Posts Qtrly Total Revenue A$1.6 Million
Brief: Universal Biosensors Says John Sharman Steps Down As Managing Director And CEO